Both AGX and MTZ sit at the center of one of the market's most visible themes: the buildout of power generation and energy infrastructure to support rising electricity demand. Investors comparing these two names are typically weighing a focused, balance-sheet-strong specialty contractor against a diversified, multi-billion-dollar infrastructure services company. This stock comparison examines how each has performed recently, what is driving relative performance, and how their market positioning and risk profiles contrast in the current environment.
AGX is Argan, Inc., a U.S.-based construction company operating primarily through its Gemma Power Systems and Atlantic Projects Company subsidiaries, which provide engineering, procurement, construction, and maintenance services to the power-generation market, including gas-fired and renewable projects. The company also offers industrial construction services through The Roberts Company and telecommunications infrastructure work through Southern Maryland Cable.
Recent market activity has reflected strong investor enthusiasm tied to power-plant construction demand. In its most recent quarter, Argan reported revenue of about $251 million and diluted earnings per share (EPS, the profit allocated to each outstanding share) of $2.17. Management highlighted a record consolidated backlog of approximately $3.0 billion, up from roughly $1.4 billion at the start of the fiscal year, driven in part by new gas-fired project awards in Texas. The company's debt-free balance sheet, with a rising cash and investment position, has reinforced sentiment. Notably, the stock's year-to-date advance has been substantial, though some analysts have recently tempered their ratings even as they raised price targets, reflecting valuation considerations after the strong run. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
MTZ is MasTec, Inc., a diversified infrastructure construction services provider headquartered in Coral Gables, Florida. Its segments span communications, pipeline infrastructure, power delivery, and clean energy and infrastructure, serving utilities, energy, and broadband customers across the U.S. and internationally.
Recent quarters have shown broad-based momentum. For fiscal 2025, MasTec reported revenue of roughly $14.3 billion, up 16% year over year, with growth across most segments. Its 18-month backlog reached a record near $19 billion, an increase of more than 30% from the prior year, supported by demand for grid reliability, data-center connectivity, and renewable infrastructure. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA, a profitability measure) also rose. Analyst coverage has leaned positive, with a consensus in the "strong buy" range in recent reports. At the same time, the company carries a larger and more leveraged capital structure than Argan, and its performance is more exposed to project timing, permitting delays, and weather-related disruptions.
The clearest contrast between AGX and MTZ is scale and focus. Argan is a niche specialist concentrated in power-generation construction, giving it a simpler, cleaner story but narrower end-market exposure. MasTec is a diversified platform spanning communications, pipelines, power delivery, and clean energy, which spreads risk but also introduces more moving parts in project execution.
Growth drivers differ accordingly. Argan's outlook hinges on a historically large backlog of power-plant work and an unusually strong, debt-free balance sheet. MasTec's growth is tied to multi-year themes such as broadband expansion, grid modernization, renewables, and data-center demand, supported by an acquisition strategy. On risk, MasTec faces permitting and weather-related project timing risk, while Argan's elevated valuation and dependence on large contract awards represent its own vulnerabilities. Market sentiment has been broadly constructive for both, though Argan's recent momentum and financial conservatism contrast with MasTec's larger footprint and higher leverage.
Weighing trend consistency, balance-sheet stability, and relative positioning, Tickeron's AI would likely favor AGX in the current environment. Argan's debt-free capital structure, record backlog, and sustained upward momentum present a comparatively cleaner trend profile than MasTec's more complex, leveraged operating model. That said, the assessment is probabilistic rather than definitive: MasTec's scale and diversification offer distinct advantages, and the outlook could shift with changes in project awards, margins, or broader market conditions. From what I see, this distinction matters for how each name might respond to shifts in infrastructure spending.
I have found Tickeron’s AI Trading Bots useful for monitoring how automated strategies handle names like these. The platform offers a range of bots built around different styles, timeframes, and performance histories, allowing a data-driven look at relative positioning without relying solely on manual charts. In practice, reviewing the curated options helps align ideas with individual risk parameters and objectives.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MTZ declined for three days, in 221 of 284 cases, the price declined further within the following month. The odds of a continued downward trend are 78%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MTZ as a result. In 57 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for MTZ turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 37 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
The Aroon Indicator for MTZ entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for MTZ's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +18.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where MTZ advanced for three days, in 278 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
MTZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.021) is normal, around the industry mean (15.143). P/E Ratio (27.461) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (0.616) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.215) among similar stocks. P/S Ratio (1.103) is also within normal values, averaging (2.886).
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. MTZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a infrastructure construction company
Industry EngineeringConstruction